UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000060399
Receipt number R000069092
Scientific Title Mixed Reality-Based Education Using a Three-Dimensional Anatomical Model For Pancreatobiliary Endoscopic Procedures: A Multicenter Study
Date of disclosure of the study information 2026/01/19
Last modified on 2026/01/18 14:22:15

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Mixed Reality-Based Education Using a Three-Dimensional Anatomical Model For Pancreatobiliary Endoscopic Procedures: A Multicenter Study

Acronym

Mixed Reality-Based Education Using a Three-Dimensional Anatomical Model For Pancreatobiliary Endoscopic Procedures

Scientific Title

Mixed Reality-Based Education Using a Three-Dimensional Anatomical Model For Pancreatobiliary Endoscopic Procedures: A Multicenter Study

Scientific Title:Acronym

Mixed Reality-Based Education Using a Three-Dimensional Anatomical Model For Pancreatobiliary Endoscopic Procedures

Region

Japan


Condition

Condition

biliary stricture, pancreatic duct stricture

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

This study aims to evaluate the usefulness of education on ERCP-related procedures using three-dimensional (3D) models within mixed reality (MR), including its applicability to remote education.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Pre and post education changes in trainees' scores assessing (1) comprehension of three-dimensional anatomical structures and (2) ability to develop procedural strategies using three-dimensional (3D) models in mixed reality (MR).

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Educational,Counseling,Training

Type of intervention

Device,equipment

Interventions/Control_1

Participants receive pre-procedural training using three-dimensional (3D) models within mixed reality (MR).

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients aged 20 years or older who undergo ERCP-related procedures after receiving pre-procedural education using three-dimensional (3D) models in mixed reality (MR) between the date of IRB approval for this clinical study and March 31, 2029.

Key exclusion criteria

(1) Withdrawal of consent by the participant.
(2) Any other case deemed unsuitable for participation by the principal investigator or subinvestigator.

Target sample size

600


Research contact person

Name of lead principal investigator

1st name Yuki
Middle name
Last name Tanisaka

Organization

Saitama Medical University International Medical Center

Division name

Gastroenterology

Zip code

3501298

Address

1397-1, Yamane, Hidaka, Saitama 350-1298, Japan

TEL

0429844111

Email

tanisaka1205@gmail.com


Public contact

Name of contact person

1st name Yuki
Middle name
Last name Tanisaka

Organization

Saitama Medical University International Medical Center

Division name

Gastroenterology

Zip code

3501298

Address

1397-1, Yamane, Hidaka, Saitama 350-1298, Japan

TEL

0429844111

Homepage URL


Email

tanisaka1205@gmail.com


Sponsor or person

Institute

Saitama Medical University International Medical Center

Institute

Department

Personal name



Funding Source

Organization

Saitama Medical University International Medical Center

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Saitama Medical University International Medical Center

Address

1397-1, Yamane, Hidaka, Saitama, JAPAN

Tel

0429844111

Email

tanisaka1205@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW

Not required for this country


Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 01 Month 19 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2026 Year 01 Month 07 Day

Date of IRB

2026 Year 01 Month 07 Day

Anticipated trial start date

2026 Year 04 Month 01 Day

Last follow-up date

2030 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2026 Year 01 Month 18 Day

Last modified on

2026 Year 01 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000069092